Table 4 Influence of channels
| Â | Drug | Cell-line | ||
|---|---|---|---|---|
Channel | DSE | MFE | mEE | CNE |
\(CC_{p}\) | 22.8% | 30.5% | 24.4% | 22.3% |
\(R^{2}\) | 21.4% | 33.4% | 23.8% | 21.4% |
RMSE | 20.0% | 32.9% | 24.7% | 22.4% |
\(CC_{s}\) | 22.6% | 32.3% | 24.3% | 20.8% |
| Â | Drug | Cell-line | ||
|---|---|---|---|---|
Channel | DSE | MFE | mEE | CNE |
\(CC_{p}\) | 22.8% | 30.5% | 24.4% | 22.3% |
\(R^{2}\) | 21.4% | 33.4% | 23.8% | 21.4% |
RMSE | 20.0% | 32.9% | 24.7% | 22.4% |
\(CC_{s}\) | 22.6% | 32.3% | 24.3% | 20.8% |